NBIX: Neurocrine Biosciences, Inc. Stock

by  •  • Comments Off on NBIX: Neurocrine Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 14,090.32
Enterprise Value ($M) 13,228.82
Book Value ($M) 2,232.00
Book Value / Share 22.19
Price / Book 6.31
NCAV ($M) 587.60
NCAV / Share 5.84
Price / NCAV 23.98

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.11
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 2.40
Current Ratio 2.45

Balance Sheet (mrq) ($M)
Current Assets 1,607.00
Assets 3,251.40
Liabilities 1,019.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,887.10
Operating Income 394.80
Net Income 249.70
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 389.90
Cash from Investing -467.10
Cash from Financing 65.30

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.88 3.96
01-23 13G/A BlackRock Inc. 13.90 8.08

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-09 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 94,760 739,418 12.82
2024-04-23 233,957 1,607,818 14.55
2024-04-22 121,979 260,987 46.74
2024-04-19 79,919 212,763 37.56

(click for more detail)

Similar Companies
MRVI – Maravai LifeSciences Holdings, Inc. MTEX – Mannatech, Incorporated
MYGN – Myriad Genetics, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc.


Financial data and stock pages provided by
Fintel.io